TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Galecto Biotech AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
|
8,123
|
0 |
Financial expenses |
1,871
|
7,380
|
128 |
Earnings before taxes |
-227,828
|
-373,552
|
-26,032 |
EBITDA |
-227,381
|
-366,908
|
-26,187 |
Total assets |
61,054
|
132,244
|
10,394 |
Current assets |
31,973
|
95,248
|
8,279 |
Current liabilities |
47,840
|
113,880
|
1,745 |
Equity capital |
13,214
|
18,364
|
8,649 |
- share capital |
1,811
|
1,806
|
177 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
21.6%
|
13.9%
|
83.2% |
Turnover per employee |
0
|
4,062
|
0 |
Profit as a percentage of turnover | -4598.7% | ||
Return on assets (ROA) |
-370.1%
|
-276.9%
|
-249.2% |
Current ratio |
66.8%
|
83.6%
|
474.4% |
Return on equity (ROE) |
-1724.1%
|
-2034.2%
|
-301.0% |
Change turnover |
-8,165
|
8,123
|
0 |
Change turnover % | -100% | ||
Chg. No. of employees |
0
![]() |
0
|
1 |
Chg. No. of employees % |
0%
![]() |
0%
|
100% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.